Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The report details the trend, potential and market size of RNAi for Therapeutic Consumption market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of RNAi for Therapeutic Consumptionmarket, defines the market attractiveness level of RNAi for Therapeutic Consumption market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of RNAi for Therapeutic Consumption industry, describes the types of RNAi for Therapeutic Consumption market, the applications of major players and the market size, and deeply analyzes the current situation of the global RNAi for Therapeutic Consumption market and the development prospects and opportunities of RNAi for Therapeutic Consumption industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global RNAi for Therapeutic Consumption market in Chapter 13.
By Player:
Dicerna Pharmaceuticals
Alnylam Pharmaceuticals
miRagen Therapeutics
Arrowhead
Sirnaomics
RXi Pharmaceuticals
Gradalis
Quark Pharmaceuticals
Mirna Therapeutics
By Type:
siRNA
miRNA
shRNA
By End-User:
Cancer
Cardiovascular
HBV
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 RNAi for Therapeutic Consumption Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 RNAi for Therapeutic Consumption Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 RNAi for Therapeutic Consumption Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 RNAi for Therapeutic Consumption Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise RNAi for Therapeutic Consumption Market Analysis and Outlook to 2022
-
7.1 Global RNAi for Therapeutic Consumption Consumption (2017-2022)
-
7.2 United States RNAi for Therapeutic Consumption Consumption (2017-2022)
-
7.3 Europe RNAi for Therapeutic Consumption Consumption (2017-2022)
-
7.4 China RNAi for Therapeutic Consumption Consumption (2017-2022)
-
7.5 Japan RNAi for Therapeutic Consumption Consumption (2017-2022)
-
7.6 India RNAi for Therapeutic Consumption Consumption (2017-2022)
-
7.7 South Korea RNAi for Therapeutic Consumption Consumption (2017-2022)
8 Region and Country-wise RNAi for Therapeutic Consumption Market Analysis and Outlook to 2028
-
8.1 Global RNAi for Therapeutic Consumption Consumption Forecast (2022-2028)
-
8.2 United States RNAi for Therapeutic Consumption Consumption Forecast (2022-2028)
-
8.3 Europe RNAi for Therapeutic Consumption Consumption Forecast (2022-2028)
-
8.4 China RNAi for Therapeutic Consumption Consumption Forecast (2022-2028)
-
8.5 Japan RNAi for Therapeutic Consumption Consumption Forecast (2022-2028)
-
8.6 India RNAi for Therapeutic Consumption Consumption Forecast (2022-2028)
-
8.7 South Korea RNAi for Therapeutic Consumption Consumption Forecast (2022-2028)
9 Global RNAi for Therapeutic Consumption Market Outlook by Types and Applications to 2022
-
9.1 Global RNAi for Therapeutic Consumption Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global siRNA Consumption and Growth Rate (2017-2022)
-
9.1.2 Global miRNA Consumption and Growth Rate (2017-2022)
-
9.1.3 Global shRNA Consumption and Growth Rate (2017-2022)
-
9.2 Global RNAi for Therapeutic Consumption Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
9.2.3 Global HBV Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global RNAi for Therapeutic Consumption Market Outlook by Types and Applications to 2028
-
10.1 Global RNAi for Therapeutic Consumption Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global siRNA Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global miRNA Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global shRNA Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global RNAi for Therapeutic Consumption Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global HBV Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global RNAi for Therapeutic Consumption Import and Export Analysis (Top 5 Countries)
-
11.1 Global RNAi for Therapeutic Consumption Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global RNAi for Therapeutic Consumption Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 RNAi for Therapeutic Consumption Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global RNAi for Therapeutic Consumption Market Competitive Analysis
-
14.1 Dicerna Pharmaceuticals
-
14.1.1 Dicerna Pharmaceuticals Company Details
-
14.1.2 Dicerna Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Dicerna Pharmaceuticals RNAi for Therapeutic Consumption Product and Service
-
14.2 Alnylam Pharmaceuticals
-
14.2.1 Alnylam Pharmaceuticals Company Details
-
14.2.2 Alnylam Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Alnylam Pharmaceuticals RNAi for Therapeutic Consumption Product and Service
-
14.3 miRagen Therapeutics
-
14.3.1 miRagen Therapeutics Company Details
-
14.3.2 miRagen Therapeutics RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 miRagen Therapeutics RNAi for Therapeutic Consumption Product and Service
-
14.4 Arrowhead
-
14.4.1 Arrowhead Company Details
-
14.4.2 Arrowhead RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Arrowhead RNAi for Therapeutic Consumption Product and Service
-
14.5 Sirnaomics
-
14.5.1 Sirnaomics Company Details
-
14.5.2 Sirnaomics RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sirnaomics RNAi for Therapeutic Consumption Product and Service
-
14.6 RXi Pharmaceuticals
-
14.6.1 RXi Pharmaceuticals Company Details
-
14.6.2 RXi Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 RXi Pharmaceuticals RNAi for Therapeutic Consumption Product and Service
-
14.7 Gradalis
-
14.7.1 Gradalis Company Details
-
14.7.2 Gradalis RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Gradalis RNAi for Therapeutic Consumption Product and Service
-
14.8 Quark Pharmaceuticals
-
14.8.1 Quark Pharmaceuticals Company Details
-
14.8.2 Quark Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Quark Pharmaceuticals RNAi for Therapeutic Consumption Product and Service
-
14.9 Mirna Therapeutics
-
14.9.1 Mirna Therapeutics Company Details
-
14.9.2 Mirna Therapeutics RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Mirna Therapeutics RNAi for Therapeutic Consumption Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of RNAi for Therapeutic Consumption
-
Figure RNAi for Therapeutic Consumption Picture
-
Table Global RNAi for Therapeutic Consumption Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNAi for Therapeutic Consumption Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNAi for Therapeutic Consumption Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global RNAi for Therapeutic Consumption Consumption by Country (2017-2022)
-
Figure United States RNAi for Therapeutic Consumption Consumption and Growth Rate (2017-2022)
-
Table Europe RNAi for Therapeutic Consumption Consumption and Growth Rate (2017-2022)
-
Figure China RNAi for Therapeutic Consumption Consumption and Growth Rate (2017-2022)
-
Figure Japan RNAi for Therapeutic Consumption Consumption and Growth Rate (2017-2022)
-
Figure India RNAi for Therapeutic Consumption Consumption and Growth Rate (2017-2022)
-
Figure South Korea RNAi for Therapeutic Consumption Consumption and Growth Rate (2017-2022)
-
Figure Global RNAi for Therapeutic Consumption Consumption Forecast by Country (2022-2028)
-
Figure United States RNAi for Therapeutic Consumption Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe RNAi for Therapeutic Consumption Consumption Forecast and Growth Rate (2022-2028)
-
Figure China RNAi for Therapeutic Consumption Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan RNAi for Therapeutic Consumption Consumption Forecast and Growth Rate (2022-2028)
-
Figure India RNAi for Therapeutic Consumption Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea RNAi for Therapeutic Consumption Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global siRNA Consumption and Growth Rate (2017-2022)
-
Figure Global miRNA Consumption and Growth Rate (2017-2022)
-
Figure Global shRNA Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
Figure Global HBV Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global siRNA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global miRNA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global shRNA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HBV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global RNAi for Therapeutic Consumption Import by Region (Top 5 Countries) (2017-2028)
-
Table Global RNAi for Therapeutic Consumption Export by Region (Top 5 Countries) (2017-2028)
-
Table Dicerna Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Dicerna Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dicerna Pharmaceuticals RNAi for Therapeutic Consumption Product and Service
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals RNAi for Therapeutic Consumption Product and Service
-
Table miRagen Therapeutics (Foundation Year, Company Profile and etc.)
-
Table miRagen Therapeutics RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
Table miRagen Therapeutics RNAi for Therapeutic Consumption Product and Service
-
Table Arrowhead (Foundation Year, Company Profile and etc.)
-
Table Arrowhead RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arrowhead RNAi for Therapeutic Consumption Product and Service
-
Table Sirnaomics (Foundation Year, Company Profile and etc.)
-
Table Sirnaomics RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sirnaomics RNAi for Therapeutic Consumption Product and Service
-
Table RXi Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table RXi Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
Table RXi Pharmaceuticals RNAi for Therapeutic Consumption Product and Service
-
Table Gradalis (Foundation Year, Company Profile and etc.)
-
Table Gradalis RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gradalis RNAi for Therapeutic Consumption Product and Service
-
Table Quark Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Quark Pharmaceuticals RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quark Pharmaceuticals RNAi for Therapeutic Consumption Product and Service
-
Table Mirna Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Mirna Therapeutics RNAi for Therapeutic Consumption Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mirna Therapeutics RNAi for Therapeutic Consumption Product and Service
-
